Englert, K.A.; Dyduch, G.; Kłosowicz, A.; Spałkowska, M.; Jaworek, A.K.; Migacz-Gruszka, K.; Jarosz-Chudek, A.; Mercuri, S.R.; Szpor, J.; Mazzoccoli, G.;
et al. Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus. Medicina 2023, 59, 2022.
https://doi.org/10.3390/medicina59112022
AMA Style
Englert KA, Dyduch G, Kłosowicz A, Spałkowska M, Jaworek AK, Migacz-Gruszka K, Jarosz-Chudek A, Mercuri SR, Szpor J, Mazzoccoli G,
et al. Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus. Medicina. 2023; 59(11):2022.
https://doi.org/10.3390/medicina59112022
Chicago/Turabian Style
Englert, Karolina A., Grzegorz Dyduch, Agata Kłosowicz, Magdalena Spałkowska, Andrzej Kazimierz Jaworek, Kamila Migacz-Gruszka, Aleksandra Jarosz-Chudek, Santo Raffaele Mercuri, Joanna Szpor, Gianluigi Mazzoccoli,
and et al. 2023. "Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus" Medicina 59, no. 11: 2022.
https://doi.org/10.3390/medicina59112022
APA Style
Englert, K. A., Dyduch, G., Kłosowicz, A., Spałkowska, M., Jaworek, A. K., Migacz-Gruszka, K., Jarosz-Chudek, A., Mercuri, S. R., Szpor, J., Mazzoccoli, G., Damiani, G., & Wojas-Pelc, A.
(2023). Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus. Medicina, 59(11), 2022.
https://doi.org/10.3390/medicina59112022
